Published in Blood Weekly, June 12th, 2003
MDSs are malignant disorders of blood cell production and affect approximately 250,000-300,000 people worldwide, and which eventually lead to acute leukemia. The study shows that Revimid reduced or eliminated the need for red blood cell transfusions in anemic patients who had been using transfusions.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.